Evidence check: Stuhlprobe in the context of Blutzucker

The question about a stool sample in the context of blood sugar refers to gut microbiome analysis. Mechanistic evidence suggests that the gut microbiota can influence glucose metabolism via short-chain fatty acids, inflammatory mediators, and incretin modulation. However, the evidence for direct, clinically actionable predictions of blood sugar from a single stool sample is weak. Most consumer tests rely on association studies with small effect sizes and lack standardized reference ranges. Moreover, the microbiome fluctuates significantly with daily diet and timing. Without concurrent blood glucose measurements (e.g., continuous glucose monitoring) and without accounting for diet, exercise, and medication, the interpretability is limited. A responsible application might be within personalized nutrition coaching with repeated sampling, but not as a standalone diagnostic or preventive marker. The evidence level is best described as 'mechanistic' to 'unclear'. Consumers should not make therapeutic decisions based solely on a stool test.